Real-World Botulinum Toxin Type A Treatment Patterns in Patients With Spasticity

被引:0
|
作者
Gratie, Daniel [1 ]
Mercer, Daniel W. [2 ]
Lee, Jae Hyun [3 ]
Gillard, Patrick [3 ]
机构
[1] AESARA, Chapel Hill, NC 27515 USA
[2] Genesis Res, Hoboken, NJ USA
[3] AbbVie, Irvine, CA USA
关键词
Botulinum toxin type A; Drug administration schedule; Muscle spasticity; Treatment frequency; Treatment switching;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:S23 / S23
页数:1
相关论文
共 50 条
  • [41] REAL-LIFE USE OF BOTULINUM TOXIN TYPE A IN POSTSTROKE SPASTICITY: IS THERE A TIME WINDOW TO START TREATMENT?
    Freitas, Margarida
    Rosa, Susana
    Guimaraes, Bruno
    Martins, Joana
    Mesquita, Jose Luis
    Cardoso, Daniel
    Jacinto, Jorge
    TOXICON, 2021, 190 : S26 - S26
  • [42] Treatment with botulinum toxin type B for upper-limb spasticity
    Brashear, A
    McAfee, AL
    Kuhn, ER
    Ambrosius, WT
    ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION, 2003, 84 (01): : 103 - 107
  • [43] COST-MINIMIZATION ANALYSIS OF TREATMENT OF SPASTICITY WITH BOTULINUM TOXIN TYPE A
    Tapias, G.
    Crespo, C.
    Cuesta, M.
    Forne, C.
    Garcia-Romero, M.
    Pascual-Pascual, S., I
    VALUE IN HEALTH, 2013, 16 (07) : A624 - A624
  • [44] Pooled analysis of the safety of botulinum toxin type A in the treatment of poststroke spasticity
    Turkel, Catherine C.
    Bowen, Beta
    Liu, Jingyu
    Brin, Mitchell F.
    ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION, 2006, 87 (06): : 786 - 792
  • [45] Botulinum Toxin Type A for the Treatment of Lower Limb Spasticity after Stroke
    Santamato, Andrea
    Cinone, Nicoletta
    Panza, Francesco
    Letizia, Sara
    Santoro, Luigi
    Lozupone, Madia
    Daniele, Antonio
    Picelli, Alessandro
    Baricich, Alessio
    Intiso, Domenico
    Ranieri, Maurizio
    DRUGS, 2019, 79 (02) : 143 - 160
  • [46] Determinants of discontinuation of Botulinum Toxin Type A treatment for spasticity in multiple sclerosis
    Castelli, L.
    Latino, P.
    Taborri, G.
    Prosperini, L.
    Pozzilli, C.
    Giovannelli, M.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 393 - 393
  • [47] Botulinum Toxin Type A for the Treatment of Lower Limb Spasticity after Stroke
    Andrea Santamato
    Nicoletta Cinone
    Francesco Panza
    Sara Letizia
    Luigi Santoro
    Madia Lozupone
    Antonio Daniele
    Alessandro Picelli
    Alessio Baricich
    Domenico Intiso
    Maurizio Ranieri
    Drugs, 2019, 79 : 143 - 160
  • [48] FEWER INJECTIONS OF BOTULINUM TOXIN TYPE A FOR TREATMENT OF SPASTICITY IS PERCEIVED AS BENEFICIAL BY BOTH PATIENTS AND CAREGIVERS
    Wein, Theodore
    Patel, Atul
    Bahroo, Laxman B.
    Wilczynski, Ophelie
    Rios, Carl
    Murie-Fernandez, Manuel
    TOXICON, 2018, 156 : S112 - S113
  • [49] Botulinum toxin type A in the treatment of upper limb spasticity among patients with traumatic brain injury
    Pavesi, G
    Brianti, R
    Medici, D
    Mammi, P
    Mazzucchi, A
    Mancia, D
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1998, 64 (03): : 419 - 420
  • [50] ECONOMIC EVALUATION OF BOTULINUM TOXIN TYPE A (XEOMEEN) IN THE TREATMENT OF ADULT PATIENTS WITH SPASTICITY IN THE "IMSS" AND "ISSSTE"
    Del Rosal y Hermosillo, A.
    Agramonte Hevia, J.
    Vergara Lopez, S.
    Soto Molina, H.
    Frias Gasga, A. E.
    Palomo Paz, E. J.
    Peralta-Hernandez, L. J.
    Gomez Martinez, F.
    VALUE IN HEALTH, 2024, 27 (06) : S122 - S122